Zinnia Xu

Zinnia Xu, PhD has a diverse work experience spanning various roles and industries. From 2022 to the present, they serve as the Associate Director of Business Development at ORIC Pharmaceuticals Inc. Prior to that, they were the Senior Manager of Market Insights at Allakos Inc from 2021 to 2022. From 2020 to 2021, Zinnia worked as the Manager of Commercial Analytics and Insights at Myovant Sciences. Zinnia also has experience as an Associate Consultant at ZS, where they focused on pipeline launch and strategy. Before entering the industry, Zinnia held research positions at Johns Hopkins School of Medicine and University of Washington, focusing on biomedical engineering and neurosurgery. Zinnia'searly career involved work as an ITS Helpdesk Analyst at Harborview Medical Center and as a Brain Imaging Research Assistant at the University of Washington.

Zinnia Xu, PhD, has a strong education background in the field of biomedical/medical engineering. Zinnia obtained their degree of Doctor of Philosophy (PhD) from The Johns Hopkins University School of Medicine. Prior to that, they completed their undergraduate studies at the University of Washington, where they earned a Bachelor of Science (BS) degree in Bioengineering, with minors in Mathematics and Chemistry.

In addition to their academic achievements, Zinnia has also pursued additional certifications. Zinnia obtained the certification of Advanced Open Water Diver from PADI in March 2021, showcasing their expertise in underwater activities. Furthermore, they have also obtained the certification of Freediver I from PADI, however, the specific month of achievement is not provided. These certifications demonstrate Zinnia's diverse range of skills and interests beyond their academic pursuits.